HIV Prevention Clinical Trial
Official title:
Optimizing PrEP Uptake Among Latino MSM in Puerto Rico: A Comparative Effectiveness Study
Verified date | October 2023 |
Source | University of Puerto Rico |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To develop, assess and compare the effectiveness of a Motivational Interviewing Intervention for increasing Pre-Exposure Prophylaxis (PrEP) uptake among Latino Men Who Have Sex With Men (MSM) in Puerto Rico.
Status | Recruiting |
Enrollment | 182 |
Est. completion date | May 31, 2026 |
Est. primary completion date | May 31, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 21 Years to 99 Years |
Eligibility | Latino MSM group - Inclusion Criteria: - Biological male - Age 21 or older - Self-reported HIV negative or unknown status - Not using PrEP (participants who have discontinued PrEP use can participate in the study), Spanish fluency (ability to write and read in Spanish) - Presenting at least one of the eligibility criteria for PrEP as established by the CDC (including men who have had an infection (STI) in the past 6 months, HIV positive sexual partner) - Access to a portable technology device (e.g., phone, tablet, laptop) or desktop computer access to internet connection Exclusion Criteria: - HIV positive individual - Evidence of being under the effects of alcohol or drugs - Indication of unstable or serious psychiatric symptoms - Evidence of major cognitive impairment - Inability to speak and read in Spanish Healthcare Providers group - Inclusion Criteria: - Age 21 or older - Providing PrEP related health services at time of enrollment (e.g., case management, clinical services) - Spanish fluency (ability to write and read in Spanish) Exclusion Criteria: - Evidence of being under the effects of alcohol or drugs - Indication of unstable or serious psychiatric symptoms - Evidence of major cognitive impairment - Inability to speak and read in Spanish |
Country | Name | City | State |
---|---|---|---|
Puerto Rico | University of Puerto Rico Medical Sciences Campus | San Juan |
Lead Sponsor | Collaborator |
---|---|
University of Puerto Rico |
Puerto Rico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary | PrEP uptake | 150 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03411577 -
Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program
|
N/A | |
Active, not recruiting |
NCT03112369 -
Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use
|
N/A | |
Not yet recruiting |
NCT03642314 -
HIV Self-testing in Implementation PrEP Study
|
N/A | |
Completed |
NCT01810315 -
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
|
Phase 1 | |
Completed |
NCT00984971 -
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
|
Phase 1 | |
Completed |
NCT00142935 -
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1
|
N/A | |
Active, not recruiting |
NCT03255915 -
PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)
|
Early Phase 1 | |
Completed |
NCT05037513 -
Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
|
N/A | |
Recruiting |
NCT05087680 -
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
|
N/A | |
Completed |
NCT03148171 -
Project WERK (Wellness Encouragement Respect Kinship)
|
N/A | |
Completed |
NCT04791007 -
OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults
|
Early Phase 1 | |
Recruiting |
NCT05412433 -
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
|
N/A | |
Active, not recruiting |
NCT03977181 -
The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms
|
N/A | |
Recruiting |
NCT05165745 -
Stick2PrEP Cisgender Women and Trans Individuals
|
N/A | |
Completed |
NCT03719053 -
Single Dose Truvada Study
|
Phase 1 | |
Recruiting |
NCT03856580 -
Long-acting Biomedical HIV Prevention in Transgender Women
|
N/A | |
Completed |
NCT02750540 -
Optimization of a Tenofovir Enema for HIV Prevention
|
Phase 1 | |
Completed |
NCT01386294 -
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
|
Phase 3 | |
Completed |
NCT00993811 -
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
|
Phase 1 | |
Completed |
NCT01028157 -
S.T.A.R.S.: Sistas Talking About Real Solutions
|
Phase 1 |